Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma

CONTEXT: Neoadjuvant chemotherapy is increasingly used in borderline resectable and locally advanced pancreatic cancer to facilitate surgical resection. OBJECTIVE: To compare progression free survival and overall survival in patients receiving neoadjuvant FOLFIRINOX with those receiving gemcitabine/...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JOP
Autores principales: Chapman, Brandon C, Gleisner, Ana, Rigg, Devin, Messersmith, Wells, Paniccia, Alessandro, Meguid, Cheryl, Gajdos, Csaba, McCarter, Martin D, Schulick, Richard D, Edil, Barish H
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018015/
https://ncbi.nlm.nih.gov/pubmed/29950957
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares